Devices/Equipment

TEAM Technologies Acquires TAG3 Engineering, Expanding Medical Device Development Capabilities

TEAM Technologies is expanding its medical device capabilities to include front-end design and innovation. The company announced the acquisition of TAG3 Engineering, a Florida-based design, development, and manufacturing firm that adds these capabilities to TEAM’s existing manufacturing operations. Key Points […]

TEAM Technologies Acquires TAG3 Engineering, Expanding Medical Device Development Capabilities Read More »

Johns Hopkins Study Tests Whether Teen Athletes Will Consistently Wear Fitness Trackers During Recovery

Consumer-grade fitness trackers like the Fitbit Sense may offer a practical tool for future monitoring studies of adolescent athletes recovering from sports injuries, according to a feasibility study that found high device adherence rates but did not evaluate clinical effectiveness.

Johns Hopkins Study Tests Whether Teen Athletes Will Consistently Wear Fitness Trackers During Recovery Read More »

Codex Genetics Partners with Pacific Edge for Bladder Cancer Testing in Hong Kong

Bladder cancer’s high recurrence rate and lifelong monitoring requirements make it one of the most expensive cancers to manage globally. Hong Kong-based precision diagnostics company Codex Genetics recently announced an exclusive collaboration with Pacific Edge to bring non-invasive genomic urine

Codex Genetics Partners with Pacific Edge for Bladder Cancer Testing in Hong Kong Read More »

Children’s Hospital Colorado Updates Gait Lab with New Camera System

Children’s Hospital Colorado’s Center for Gait and Movement Analysis serves as the only accredited clinical gait and movement analysis lab in its region, evaluating hundreds of pediatric patients with movement disorders annually. The Aurora-based facility recently upgraded to Vicon’s Valkyrie

Children’s Hospital Colorado Updates Gait Lab with New Camera System Read More »

Principal Technologies Signs Letter of Intent to Acquire Swiss Medical Research Company for $44 Million

A Canadian healthcare acquisition company is continuing to build its portfolio of healthcare technology companies. Principal Technologies Inc. announced on December 11, 2024, that it signed a non-binding letter of intent to acquire a 70.7% controlling interest in Syndermix AG,

Principal Technologies Signs Letter of Intent to Acquire Swiss Medical Research Company for $44 Million Read More »